+919405117673

Giotrif (Afatinib) Tablets – Reliable Oncology Supply from Cordium Pharmaceuticals Pvt. Ltd.

Looking for a verified pharmaceutical exporter of Giotrif (Afatinib) Tablets 20mg, 30mg, and 40mg with global delivery assurance?

Cordium Pharmaceuticals Pvt. Ltd. is a leading India-based international pharma exporter supplying oncology-grade targeted therapy medicines to regulated and semi-regulated markets worldwide.

We ensure fast, compliant, and secure delivery to:

🇺🇸 United States
🇩🇪 Germany
🇬🇧 United Kingdom
🇦🇪 United Arab Emirates
🇿🇦 South Africa
🇧🇷 Brazil
🇸🇬 Singapore
🇦🇺 Australia
🇨🇦 Canada


💊 Giotrif (Afatinib) Tablets – Complete Product Insight

Giotrif contains Afatinib Dimaleate, a clinically approved irreversible EGFR tyrosine kinase inhibitor (TKI) used in advanced oncology treatment protocols.

It is widely prescribed for:

  • EGFR mutation-positive Non-Small Cell Lung Cancer (NSCLC)
  • Metastatic lung cancer requiring targeted therapy
  • Patients requiring oral precision oncology treatment
  • Cases where EGFR/HER2 pathway inhibition is needed

📦 Available Strengths for Global Export

We supply internationally in verified strengths:

  • Giotrif 20 mg Tablets – dose adjustment strength
  • Giotrif 30 mg Tablets – intermediate therapeutic dose
  • Giotrif 40 mg Tablets – standard clinical dose for NSCLC

All products are supplied with proper labeling, batch traceability, and export-ready packaging.


🧬 Mechanism of Action (Clinical Overview)

Afatinib works by:

✔ Irreversibly blocking EGFR receptor signaling
✔ Inhibiting tumor cell proliferation pathways
✔ Reducing cancer cell survival and growth
✔ Acting on HER2 and HER4 receptors as well

This makes Giotrif a highly effective targeted therapy option in modern oncology treatment.


📈 Why Giotrif Demand Is Growing Globally

  • Rising cases of lung cancer worldwide
  • Increasing adoption of targeted oral therapies
  • Preference for precision oncology drugs
  • Strong inclusion in international treatment guidelines
  • Growth in EGFR mutation testing

🚚 Cordium Pharmaceuticals – Why Global Buyers Choose Us

🌐 1. Certified Indian Pharmaceutical Exporter

We operate as a trusted exporter of oncology and specialty medicines with global distribution capability.

⚡ 2. Fast International Shipping Network

We provide efficient and reliable logistics support to:

  • North America
  • Europe
  • Middle East
  • Africa
  • Asia-Pacific
  • Latin America

📄 3. Complete Export Documentation Support

We assist with:

  • Commercial invoice & packing list
  • Certificate of analysis (COA)
  • Shipping compliance documents
  • Customs clearance coordination

🧊 4. Quality & Compliance Driven Supply Chain

All medicines are sourced from regulated manufacturing partners ensuring:

  • GMP compliance
  • Batch consistency
  • Pharmaceutical-grade packaging

🏥 5. Bulk Supply for Healthcare Buyers

We serve:

  • International pharma distributors
  • Oncology hospitals
  • Government procurement agencies
  • Licensed importers & wholesalers

🌎 Country-Focused Supply Advantage

We specialize in export logistics for:

🇺🇸 USA – regulated oncology distribution support
🇩🇪 Germany – EU-compliant pharma supply chain
🇬🇧 UK – hospital & distributor supply
🇦🇪 UAE – fast import clearance support
🇿🇦 South Africa – reliable oncology sourcing
🇧🇷 Brazil – LATAM distribution network
🇸🇬 Singapore – high-standard pharma delivery
🇦🇺 Australia – compliant medicine export supply
🇨🇦 Canada – structured pharmaceutical trade support


📊 Product Highlights (Buyer Quick View)

✔ Prescription oncology medicine
✔ Targeted EGFR inhibitor therapy
✔ Export-ready packaging
✔ Multiple strengths available
✔ Global delivery support
✔ Trusted Indian pharmaceutical exporter


⚠️ Medical Disclaimer

Giotrif (Afatinib) is a prescription-only oncology medication and must be used strictly under the supervision of a qualified healthcare professional or oncologist.


📦 Cordium Pharmaceuticals Pvt. Ltd.

Trusted Global Exporter of Oncology & Specialty Medicines from India

🌍 Exporting to USA | Europe | Middle East | Africa | Asia-Pacific
🚀 Fast, reliable & compliant pharmaceutical supply chain

Jun 12th, 2026 11:28 AM